Adjuvant chemotherapy in breast cancer.

Adjuvant chemotherapy in breast cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Adjuvant chemotherapy in breast cancer. Abstract Text:

R Nissen-Meyer,K Kjellgren,B Mansson,

One single course of i.v. cyclophosphamide (30 mg/kg) was given over a 6-day period to 559 mastectomized patients. During a follow-up period of up to 15 years, 241 recurrence and 234 deaths are registered in this group, and 294 recurrences and 283 deaths in the randomized control group of 577 patients. Analysis of the life-table curves shows an increased cure rate of about 10%.

Adjuvant chemotherapy in breast cancer. Publishing Authors By Initials

R Nissen-Meyer,K Kjellgren,B Mansson,

For similar surgical procedures, operative: mastectomy research abstracts see: surgical procedures, operative: mastectomy research

PUBMED ID PMID:

MEDLINE DATE:

Adjuvant chemotherapy in breast cancer. Journal Published:

PUBLICATION TYPE: Randomized Controlled Trial

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 80

Page Numbers: 142-8

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1982

Adjuvant chemotherapy in breast cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 44671

Adjuvant chemotherapy in breast cancer. Keywords Mesh Terms:

KEYWORDS: Mastectomy

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Adjuvant chemotherapy in breast cancer. Information

Substance Name: Cyclophosphamide

Registry Number: 50-18-0

Grant and Affiliation Information for Adjuvant chemotherapy in breast cancer.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Adjuvant chemotherapy in breast cancer Related Publications

• Adjuvant chemotherapy in breast cancer.
• Mycobacteria from aquaria.
• Preliminary report from the Scandinavian adjuvant chemotherapy study group.
• The intestinal flora in horses with certain skin changes; with special reference to the coliform microbes.
• Use of receptor chimeras to identify small molecules with high affinity for the dynorphin A binding domain of the kappa opioid receptor.